Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol
- PMID: 791333
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol
Abstract
1 The actions of labetalol 1.0-2.0 mg/kg intravenously on blood pressure, heart rate, plasma angiotensin II and aldosterone concentrations have been studied in 20 recumbent hypertensive patients. 2 In all subjects there was a reduction in systolic and diastolic blood pressures within 5 min of completion of injection. 3 Severe hypotension was not seen but three patients who had a marked fall in blood pressure experienced side-effects. Postural hypotension was common at the end of the study. 4 Labetalol caused significant reduction in heart rate. 5 Labetalol induced significant lowering of plasma angiotensin II and in plasma aldosterone concentrations, which were most obvious when these were increased initially; overall there was a close correlation between concurrent measurements of angiotensin II and aldosterone concentrations. 6 In five patients a comparison was made against propranolol 10 mg intravenously. Labetalol was more effective in lowering blood pressure but less effective in reducing pulse rate of plasma angiotensin II concentration.
Similar articles
-
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.Clin Sci Mol Med Suppl. 1976 Dec;3:497s-499s. doi: 10.1042/cs051497s. Clin Sci Mol Med Suppl. 1976. PMID: 1071671 Clinical Trial.
-
[Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].Nouv Presse Med. 1980 Sep 27;9(35):2565-8. Nouv Presse Med. 1980. PMID: 7001349 French.
-
Controlled comparison of labetalol and propranolol in the management of severe hypertension.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):777-82. Br J Clin Pharmacol. 1976. PMID: 791331 Clinical Trial.
-
Pharmacological effects of labetalol in man.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3. Br J Clin Pharmacol. 1976. PMID: 10949 Review.
-
Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs. 1984;28 Suppl 2:35-50. doi: 10.2165/00003495-198400282-00004. Drugs. 1984. PMID: 6151890 Review.
Cited by
-
The management of hypertension.Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):129S-142S. doi: 10.1111/j.1365-2125.1986.tb02862.x. Br J Clin Pharmacol. 1986. PMID: 3530297 Free PMC article. Review. No abstract available.
-
Intravenous labetalol in the treatment of severe hypertension.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):93S-96S. doi: 10.1111/j.1365-2125.1982.tb01895.x. Br J Clin Pharmacol. 1982. PMID: 7093105 Free PMC article.
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.Eur J Clin Pharmacol. 1982;22(4):289-93. doi: 10.1007/BF00548395. Eur J Clin Pharmacol. 1982. PMID: 7049710 Clinical Trial.
-
Intravenous labetalol in hypertensive patients given by fast and slow injection.Br J Clin Pharmacol. 1978 May;5(5):401-5. doi: 10.1111/j.1365-2125.1978.tb01645.x. Br J Clin Pharmacol. 1978. PMID: 350248 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources